Micron expects fiscal Q1 revenue of $61.5B ±$1.5B as it raises fiscal 2027 CapEx plans amid tighter 2027-2028 supply-demand (NASDAQ:MU)October 1, 2026
Exscientia: A Strategic Hold In The AI-Driven Drug Discovery Sector (NASDAQ:EXAI) Finances February 26, 2024 adventtrThe Exscientia Experiment: When AI Meets Pharma Realities Exscientia’s (NASDAQ:EXAI) inventory is off 22% since my “Purchase” advice in August.…
